| Product NDC: | 13668-268 |
| Proprietary Name: | CARBAMAZEPINE |
| Non Proprietary Name: | CARBAMAZEPINE |
| Active Ingredient(s): | 200 mg/1 & nbsp; CARBAMAZEPINE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 13668-268 |
| Labeler Name: | Torrent Pharmaceuticals Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077272 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091023 |
| Package NDC: | 13668-268-05 |
| Package Description: | 500 TABLET in 1 BOTTLE (13668-268-05) |
| NDC Code | 13668-268-05 |
| Proprietary Name | CARBAMAZEPINE |
| Package Description | 500 TABLET in 1 BOTTLE (13668-268-05) |
| Product NDC | 13668-268 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CARBAMAZEPINE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20091023 |
| Marketing Category Name | ANDA |
| Labeler Name | Torrent Pharmaceuticals Limited |
| Substance Name | CARBAMAZEPINE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |